Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis
• The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse pro...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Borie, Frederic [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2022 |
|---|
| Übergeordnetes Werk: |
Enthalten in: A 4.5 - Holmes, Jason ELSEVIER, 2018, Amsterdam |
|---|---|
| Übergeordnetes Werk: |
volume:46 ; year:2022 ; number:3 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.clinre.2021.101856 |
|---|
| Katalog-ID: |
ELV057231966 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV057231966 | ||
| 003 | DE-627 | ||
| 005 | 20230625001250.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220808s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.clinre.2021.101856 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001768.pica |
| 035 | |a (DE-627)ELV057231966 | ||
| 035 | |a (ELSEVIER)S2210-7401(21)00234-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 530 |q VZ |
| 084 | |a 33.05 |2 bkl | ||
| 084 | |a 33.07 |2 bkl | ||
| 084 | |a 33.40 |2 bkl | ||
| 100 | 1 | |a Borie, Frederic |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis |
| 264 | 1 | |c 2022 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line | ||
| 700 | 1 | |a Dubray, Vincent |4 oth | |
| 700 | 1 | |a Tretarre, Brigitte |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Masson |a Holmes, Jason ELSEVIER |t A 4.5 |d 2018 |g Amsterdam |w (DE-627)ELV000519456 |
| 773 | 1 | 8 | |g volume:46 |g year:2022 |g number:3 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.clinre.2021.101856 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 33.05 |j Experimentalphysik |q VZ |
| 936 | b | k | |a 33.07 |j Spektroskopie |q VZ |
| 936 | b | k | |a 33.40 |j Kernphysik |q VZ |
| 951 | |a AR | ||
| 952 | |d 46 |j 2022 |e 3 |h 0 | ||
| author_variant |
f b fb |
|---|---|
| matchkey_str |
boriefredericdubrayvincenttretarrebrigit:2022----:matfeomnainadeteaisnhponssfoocnewt |
| hierarchy_sort_str |
2022 |
| bklnumber |
33.05 33.07 33.40 |
| publishDate |
2022 |
| allfields |
10.1016/j.clinre.2021.101856 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001768.pica (DE-627)ELV057231966 (ELSEVIER)S2210-7401(21)00234-5 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Borie, Frederic verfasserin aut Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line Dubray, Vincent oth Tretarre, Brigitte oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:3 pages:0 https://doi.org/10.1016/j.clinre.2021.101856 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 3 0 |
| spelling |
10.1016/j.clinre.2021.101856 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001768.pica (DE-627)ELV057231966 (ELSEVIER)S2210-7401(21)00234-5 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Borie, Frederic verfasserin aut Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line Dubray, Vincent oth Tretarre, Brigitte oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:3 pages:0 https://doi.org/10.1016/j.clinre.2021.101856 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 3 0 |
| allfields_unstemmed |
10.1016/j.clinre.2021.101856 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001768.pica (DE-627)ELV057231966 (ELSEVIER)S2210-7401(21)00234-5 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Borie, Frederic verfasserin aut Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line Dubray, Vincent oth Tretarre, Brigitte oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:3 pages:0 https://doi.org/10.1016/j.clinre.2021.101856 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 3 0 |
| allfieldsGer |
10.1016/j.clinre.2021.101856 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001768.pica (DE-627)ELV057231966 (ELSEVIER)S2210-7401(21)00234-5 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Borie, Frederic verfasserin aut Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line Dubray, Vincent oth Tretarre, Brigitte oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:3 pages:0 https://doi.org/10.1016/j.clinre.2021.101856 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 3 0 |
| allfieldsSound |
10.1016/j.clinre.2021.101856 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001768.pica (DE-627)ELV057231966 (ELSEVIER)S2210-7401(21)00234-5 DE-627 ger DE-627 rakwb eng 530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Borie, Frederic verfasserin aut Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis 2022 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line Dubray, Vincent oth Tretarre, Brigitte oth Enthalten in Elsevier Masson Holmes, Jason ELSEVIER A 4.5 2018 Amsterdam (DE-627)ELV000519456 volume:46 year:2022 number:3 pages:0 https://doi.org/10.1016/j.clinre.2021.101856 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 33.05 Experimentalphysik VZ 33.07 Spektroskopie VZ 33.40 Kernphysik VZ AR 46 2022 3 0 |
| language |
English |
| source |
Enthalten in A 4.5 Amsterdam volume:46 year:2022 number:3 pages:0 |
| sourceStr |
Enthalten in A 4.5 Amsterdam volume:46 year:2022 number:3 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Experimentalphysik Spektroskopie Kernphysik |
| institution |
findex.gbv.de |
| dewey-raw |
530 |
| isfreeaccess_bool |
false |
| container_title |
A 4.5 |
| authorswithroles_txt_mv |
Borie, Frederic @@aut@@ Dubray, Vincent @@oth@@ Tretarre, Brigitte @@oth@@ |
| publishDateDaySort_date |
2022-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000519456 |
| dewey-sort |
3530 |
| id |
ELV057231966 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV057231966</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625001250.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinre.2021.101856</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001768.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV057231966</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S2210-7401(21)00234-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.07</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Borie, Frederic</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dubray, Vincent</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tretarre, Brigitte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Masson</subfield><subfield code="a">Holmes, Jason ELSEVIER</subfield><subfield code="t">A 4.5 </subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV000519456</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:46</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinre.2021.101856</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.05</subfield><subfield code="j">Experimentalphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.07</subfield><subfield code="j">Spektroskopie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.40</subfield><subfield code="j">Kernphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">46</subfield><subfield code="j">2022</subfield><subfield code="e">3</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Borie, Frederic |
| spellingShingle |
Borie, Frederic ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis |
| authorStr |
Borie, Frederic |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000519456 |
| format |
electronic Article |
| dewey-ones |
530 - Physics |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
530 VZ 33.05 bkl 33.07 bkl 33.40 bkl Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis |
| topic |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 |
| topic_unstemmed |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 |
| topic_browse |
ddc 530 bkl 33.05 bkl 33.07 bkl 33.40 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
v d vd b t bt |
| hierarchy_parent_title |
A 4.5 |
| hierarchy_parent_id |
ELV000519456 |
| dewey-tens |
530 - Physics |
| hierarchy_top_title |
A 4.5 |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000519456 |
| title |
Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis |
| ctrlnum |
(DE-627)ELV057231966 (ELSEVIER)S2210-7401(21)00234-5 |
| title_full |
Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis |
| author_sort |
Borie, Frederic |
| journal |
A 4.5 |
| journalStr |
A 4.5 |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
500 - Science |
| recordtype |
marc |
| publishDateSort |
2022 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Borie, Frederic |
| container_volume |
46 |
| class |
530 VZ 33.05 bkl 33.07 bkl 33.40 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Borie, Frederic |
| doi_str_mv |
10.1016/j.clinre.2021.101856 |
| dewey-full |
530 |
| title_sort |
impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis |
| title_auth |
Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis |
| abstract |
• The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line |
| abstractGer |
• The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line |
| abstract_unstemmed |
• The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
3 |
| title_short |
Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis |
| url |
https://doi.org/10.1016/j.clinre.2021.101856 |
| remote_bool |
true |
| author2 |
Dubray, Vincent Tretarre, Brigitte |
| author2Str |
Dubray, Vincent Tretarre, Brigitte |
| ppnlink |
ELV000519456 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth |
| doi_str |
10.1016/j.clinre.2021.101856 |
| up_date |
2024-07-06T22:39:16.766Z |
| _version_ |
1803871119493562368 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV057231966</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625001250.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220808s2022 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.clinre.2021.101856</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001768.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV057231966</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S2210-7401(21)00234-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.05</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.07</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">33.40</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Borie, Frederic</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Impact of recommendations and new therapies on the prognosis of colon cancer with synchronous liver metastasis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2022</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The recommendation of first-line targeted agent improved survival of colon cancer with synchronous liver metastasis. • The recommendation of first-line targeted agent increased rate of primary tumor resection after chemotherapy. • Chemotherapy with targeted agent in 2nd line period had a worse prognosis than chemotherapy with TA in 1st line</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dubray, Vincent</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tretarre, Brigitte</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Masson</subfield><subfield code="a">Holmes, Jason ELSEVIER</subfield><subfield code="t">A 4.5 </subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam</subfield><subfield code="w">(DE-627)ELV000519456</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:46</subfield><subfield code="g">year:2022</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.clinre.2021.101856</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.05</subfield><subfield code="j">Experimentalphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.07</subfield><subfield code="j">Spektroskopie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">33.40</subfield><subfield code="j">Kernphysik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">46</subfield><subfield code="j">2022</subfield><subfield code="e">3</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.40028 |